STRR
Star Equity Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$10.62
+0.95%Year over year
Reported trailing growth
- Revenue
- +164.8%
- EBITDA
- —
- EBIT
- -48.8%
- EPS
- -24.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +11.2%
- EBITDA
- +209.6%
- EPS
- +112.1%
Three-year CAGR
- Revenue
- -5.0%
- EBITDA
- +59.8%
- EBIT
- +56.2%
- Net income
- +43.3%
- EPS
- +47.6%
- Free cash flow
- -11.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026